1416363-98-8Relevant articles and documents
Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors
Ma, Xiao-Dong,He, Qiu-Qin,Zhang, Xuan,Yang, Shi-Qiong,Yang, Liu-Meng,Gu, Shuang-Xi,Zheng, Yong-Tang,Chen, Fen-Er,Dai, Hui-Fang
, p. 504 - 512 (2013/02/22)
A series of N-phenylarylformamide derivatives (PAFAs) with anti-wild-type HIV-1 activity (EC50 values) ranging from 0.3 nM to 5.1 nM and therapeutic index (TI) ranging from 10 616 to 271 000 were identified as novel non-nucleoside reverse trans